Skip to main content
Log in

First Report of Clinical and Microbiological Failure in the Eradication of Glycopeptide-Intermediate Methicillin-Resistant Staphylococcus aureus Carriage by Mupirocin

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670–1673

    CAS  PubMed  Google Scholar 

  2. Guerin F, Buu-Hoi A, Mainardi JL, Kac G, Colardelle N, Vaupre S, Gutmann L, Podglajen I (2000) Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol 38:2985–2988

    CAS  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention (2002) Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR 51:565–567

    PubMed  Google Scholar 

  4. Boyce JM (2001) MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 48 [Suppl A]:9–14

  5. Cookson BD (1998) The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 42:11–18

    Article  Google Scholar 

  6. Comité de l'Antibiogramme de la Société Française de Microbiologie (2002) Communiqué 2002. Société Française de Microbiologie website. http://www.sfm.asso.fr/Sect4/com2002.pdf. Cited 31 December 2002

  7. Allen GP, Cha R, Rybak MJ (2002) In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 46:2606–2612

    Article  CAS  PubMed  Google Scholar 

  8. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP, Jones ME (1998) The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 42:489–495

    Google Scholar 

  9. Von Eiff C, Kipp F, Becker K (2002) Intranasal mupirocin to prevent postoperative infections. N Engl J Med 347:1207–1208

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. W. Decousser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Decousser, J.W., Pina, P., Ghnassia, J.C. et al. First Report of Clinical and Microbiological Failure in the Eradication of Glycopeptide-Intermediate Methicillin-Resistant Staphylococcus aureus Carriage by Mupirocin. Eur J Clin Microbiol Infect Dis 22, 318–319 (2003). https://doi.org/10.1007/s10096-003-0929-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-003-0929-z

Keywords

Navigation